
|Slideshows|June 25, 2018
Refined Prediction of MACE in Subclinical Atherosclerosis
Author(s)Veronica Hackenthal, MD
New study finds that noninvasive assessment of CAD with CCTA may help reclassify risk and predict MACE in asymptomatic atherosclerosis.
Advertisement
Source: Guaricci AI, Lorenzoni V, Guglielmo M, et al. Prognostic relevance of subclinical coronary and carotid atherosclerosis in a diabetic and nondiabetic asymptomatic population. Clin Cardiol. 2018;41:769-777.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Alpha-Gal Syndrome: Closing an Underrecognized Allergy Diagnostic Gap
2
Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial
3
GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF
4
ORFAN-MAESTRIA: AI Predicts Cardioembolic Stroke, Atrial Fibrillation from CT Scans
5






























































